Butyrylcholinesterase deficiency
prolonged
apnea
muscle relaxants
suxamethonium
mivacurium
patients
mutations
BCHE gene
prolonged
neuromuscular block
administration
suxamethonium
discovery
novel
BCHE
c.695T
p.
Inhibition studies
kinetic analysis
molecular dynamics
mutation
disrupts
catalytic triad
silent
phenotype
activity
patient
butyrylthiocholine
BTC
benzoylcholine
values
dibucaine
fluoride
heterozygous
silent
genotype
Electrophoretic analysis
plasma
BChE
proband
mother
patient
reduced
amount
tetrameric enzyme
plasma
BChE
components
monomer
dimer
monomer-albumin conjugate
Kinetic analysis
p
Val204Asp/p
Asp70Gly-p
Ala539Thr BChE
Michaelian
behavior
BTC
substrate
catalytic parameters
BTC
atypical
enzyme
low
Vmax
consistent with
absence
activity
suxamethonium
Molecular dynamic (MD)
effect
mutation p
Val204Asp
disruption
hydrogen bonding
Gln223
Glu441
Ser198
His438
disruption
catalytic triad
functionality
substrate
MD
enzyme volume
increased
pre-denaturation state
reduced
concentration
p
Ala204Asp/p
Asp70Gly-p
Ala539Thr tetrameric enzyme
plasma
non-detectable
fast moving-bands
electrophoresis gels
